Journal Home
Search for

Volume 32, Issue 11, Pages 1921-1925 (November 2006)


View previous. 43 of 54 View next.

Inhibition of intraocular fibrin formation after infusion of low-molecular-weight heparin during combined phacoemulsification–trabeculectomy surgery

Reza Zarei, MD, Reza Azimi, MD, Sasan Moghimi, MDCorresponding Author Informationemail address, Ali Abdollahi, MD, Heidar Amini, MD, Yadollah Eslami, MD, Ghasem Fakhraii, MD

Accepted 21 June 2006.

Purpose

To evaluate the effect of intraocular infusion of dalteparin, a low-molecular-weight heparin (LMWH) administered in the infusion fluid to prevent early postoperative fibrin formation in combined phacoemulsification–trabeculectomy surgery (phacotrabeculectomy).

Setting

Farabi Eye Hospital, Tehran, Iran.

Methods

Standard combined phacotrabeculectomy was performed prospectively in a masked fashion in 60 eyes; 35 eyes received 5 IU/mL LMWH in the infusate and 25 eyes served as controls. Masked postoperative examinations assessed visual acuity, intraocular pressure (IOP), anterior chamber cell and flare, and fibrin formation with slitlamp examinations 1, 3, 7, 30, and 90 days after surgery.

Results

The rate of intraocular fibrin/membrane formation was significantly lower in the LMWH group than in the control group at each follow-up (P<.001, Student t test) . The amount of IOP was lower in LMWH group at each follow up (P<.01, Student t test). Final visual acuity was better in LMWH group (P = .03, Student t test). The frequency of synechia formation was lower in the LMWH group on day 90 (P = .002, chi-square test).

Conclusions

Infusion of dalteparin, a LMWH, may be an effective inhibitor of postoperative fibrin formation in phacotrabeculectomy surgery. It may reduce the frequency of synechia formation and improve visual acuity. It may not be associated with increased risk for intraoperative or postoperative complications at the tested dose. This drug may be a useful adjunct in combined surgery.

From the Farabi Eye Research Center, Department of Ophthalmology, Tehran University of Medical Sciences, Tehran, Iran

Corresponding Author InformationCorresponding author: Sasan Moghimi, MD, Farabi Eye Research Center, Quazvin Square, Tehran, Iran.

 Supported by a grant from Tehran University of Medical Sciences.

No author has a financial or proprietary interest in any material or method mentioned.

Drs. Ehsanollaah, Shafigh, and Ardestaani provided assistance.

PII: S0886-3350(06)01053-4

doi:10.1016/j.jcrs.2006.06.029


View previous. 43 of 54 View next.